Access AMH
Helping fertility patients plan for the family they desire
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
The Access AMH assay delivers patient results quickly through fast, automated testing. It presents consistent and dependable results with the only automated AMH immunoassay to use a recombinant human antigen. Reduces laboratory costs by 16% compared with typical manual tests for assessing ovarian reserve
Beckman Coulter launches Access AMH Advanced, an innovative test for clinicians to better personalize IVF treatments
The new Access AMH Advanced aims to provide validated cut-offs for the assessment of ovarian reserve and ovarian response as an aid for women undergoing in vitro fertilization (IVF)
Beckman Coulter launches a fully automated COVID-19 IgG test to assess antibody immune response levels
The availability of an International Standard (IS) for antibodies facilitates the standardization of SARS-CoV-2 serological methods
Beckman Coulter launches its semi-quantitative SARS-CoV-2 IgG II antibody test
Access SARS-CoV-2 IgG II test is a semi-quantitative assay that measures patient’s relative level of antibodies in response to a previous SARS-CoV-2 infection
Beckman Coulter completes first in a series of antibody neutralization studies
Access SARS-CoV-2 IgG assay shows excellent agreement with the Genscript Surrogate Virus Neutralization Test
Beckman Coulter launches SARS-CoV-2 IgM antibody test and will begin shipping to U.S. diagnostics labs
IgM assay has 95.51% positive predictive value even when disease incidence is only 3%
